United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

adienne pharma & biotech - thiotepa - powder for solution for infusion - 15mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

adienne pharma & biotech - thiotepa - powder for solution for infusion - 100mg

Canada - English - Health Canada

adienne sa - thiotepa - powder for solution - 15mg - thiotepa 15mg - antineoplastic agents

Canada - English - Health Canada

adienne sa - thiotepa - powder for solution - 100mg - thiotepa 100mg - antineoplastic agents

Canada - English - Health Canada

adienne sa - thiotepa - powder for solution - 400mg - thiotepa 400mg

United States - English - NLM (National Library of Medicine)

adienne sa - thiotepa (unii: 905z5w3gkh) (thiotepa - unii:905z5w3gkh) - thiotepa 15 mg

European Union - English - EMA (European Medicines Agency)

adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastic agents - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma.phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults.phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.

European Union - English - EMA (European Medicines Agency)

adienne s.r.l. s.u. - thiotepa - hematopoietic stem cell transplantation - antineoplastic agents - in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.". it is proposed that tepadina must be prescribed by physicians experienced in conditioning treatment prior to haematopoietic progenitor cell transplantation.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

adienne sa, switzerland - thiotepa - powder for concentrate for solution for infusion - 15 mg,

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

adienne sa, switzerland - thiotepa - powder for concentrate for solution for infusion - 100 mg,